PAUL EDER, PHD
Senior Scientific Officer, NIAID
Paul Eder is a Senior Scientific Officer and leads the Concept Acceleration Program for Diagnostics in the Office of Biodefense, Research Resources, and Translational Research (OBRRTR) in the Division of Microbiology and Infectious Diseases (DMID) at NIAID. Previously he served for eight years as Senior Medical Diagnostics Advisor and contractor at BARDA. For seven years prior he served as the Director of Assay Development at QIAGEN, where he used a Bill and Melinda Gates Foundation grant to create the first WHO pre-qualified HPV screening test for resource-limited communities worldwide. For that he won the Sydney Brenner Award for outstanding accomplishment in global R&D at QIAGEN. He completed postdoctoral fellowships in nuclear tRNA transport at the Howard Hughes Medical Institute at the University of Pennsylvania, and in catalytic RNA with Nobel laureate Sidney Altman in the Department of Biology at Yale University. His Ph.D. is in biochemistry from the University of Iowa. He holds ten issued patents and has authored 25 publications and reviews.